Living with Pancreatic Cancer

Chapter 1: What Is Pancreatic Cancer, and What Just Happened

You heard the words, and then you probably heard nothing for a few seconds. That gap, the one where the doctor kept talking and none of it landed, is common enough that it deserves a name. Call it the blank spot. Nearly everyone who gets this diagnosis describes some version of it: a hallway that felt too bright, a form they signed without reading, a drive home they don't remember. None of that means you handled it wrong.

Let's start with what the words actually mean, stripped of the fear that comes attached to them.

The plain definition

The pancreas is a long, flat organ tucked behind your stomach, roughly the size of a hand. Pancreatic cancer happens when cells inside it stop following the normal rules of growth, repair, and death that every cell in your body follows, and start multiplying without stopping. That uncontrolled growth can crowd out healthy tissue, invade nearby structures, and in some cases travel to other organs.

It is not a punishment for something you ate, drank, or did wrong, and it is not a mystery illness with no biological explanation. It is cells that stopped stopping.

Where people get tripped up is the phrase "pancreatic cancer" itself, said as if it describes one single disease with one single path. It's closer to a zip code: it tells you where the trouble is, not what kind of trouble you're dealing with. Chapter 3 goes deep on this, but you need the headline now, because it changes how you should read almost everything else in this book.

Two different diseases, one organ

The pancreas has cells that make hormones and cells that line the ducts carrying digestive juices. Cancer can start in either, and the two paths behave so differently that oncologists treat them as separate diseases wearing the same name.

The left branch is pancreatic ductal adenocarcinoma, shortened to PDAC. It starts in the cells lining the tubes that carry digestive enzymes out of the pancreas, and it accounts for more than 90% of every pancreatic cancer diagnosed. It tends to grow fast and spread early, which is a major reason it's often caught later than doctors would like.

The right branch is the pancreatic neuroendocrine tumor, or PNET, sometimes called an islet cell tumor. These start in the cells that make hormones like insulin, and they make up under 5% of cases. As a group they tend to grow more slowly, and outlooks are generally more favorable than PDAC, though PNETs themselves range from very slow-growing to more aggressive, which is exactly what your specific pathology and staging will clarify.

If you don't yet know which branch you're on, that is a completely reasonable question for your next appointment, and Chapter 6 walks through the tests that answer it definitively.

Why this crept up quietly

A common thread in the stories people tell about their diagnosis is how ordinary the early symptoms felt. Some stomach discomfort that came and went. Tiredness that seemed explainable by work, stress, or just getting older. Maybe some back pain that a chiropractor or a heating pad seemed to help, some days. None of it screamed for attention the way a lump or a sudden sharp pain might.

Part of the reason is location. The pancreas sits deep in the abdomen, behind the stomach and close to the spine, so a growing tumor doesn't press on anything you'd immediately notice. Part of the reason is biology: PDAC in particular can grow for a while before it produces symptoms specific enough to point anyone toward the pancreas rather than, say, the gallbladder or a hiatal hernia. And for some people, the first real signal wasn't a stomach symptom at all. It was a blood sugar reading. Chapter 5 is built entirely around that pattern, because it surprises so many families that it deserves its own space rather than a footnote here.

None of this is a case for guilt about symptoms you or your doctor didn't catch sooner. Vague and easy to miss describes the disease's behavior, not a verdict on anyone's attentiveness.

One symptom is the exception to "vague," and it's worth flagging on its own: yellowing of the skin or the whites of the eyes, unusually dark urine, or pale, clay-colored stools. That combination, called jaundice, happens when a tumor blocks the bile duct, and unlike fatigue or mild stomach discomfort, it's a specific, visible signal, not a vague one. If you or someone close to you notices it, contact your doctor promptly rather than waiting to see if it passes; it's often what brings people in for the diagnostic workup Chapter 6 describes, and Chapter 6 also covers ERCP, the procedure that relieves it.

However you're feeling right now, that's allowed

Some people read their pathology report five times in one sitting, hunting for a detail they missed. Some people can't look at it again for a week. Some feel a strange, almost clinical calm, and then wonder if something is wrong with them for not falling apart. Anger shows up. So does an odd, business-like focus on logistics, scheduling appointments and researching insurance while the bigger feeling waits its turn.

All of that is within the normal range of how people respond to news this size. There isn't a required emotional script to follow, and nothing about your particular reaction predicts how you'll handle what comes next.

Where the rest of this book is headed

You don't need to absorb everything at once, and you don't need to read this book cover to cover before your next appointment. Think of it as a reference you can return to as questions come up.

Chapter 2 explains what the pancreas actually does day to day, and how a tumor there disrupts both digestion and blood sugar control. Chapter 3 breaks down staging and the ductal-versus-neuroendocrine distinction in more depth, so you can place your own diagnosis on the map. Chapter 4 covers risk factors honestly, without turning it into a search for blame. Chapter 5 is devoted to the diabetes connection mentioned above. Chapters 6 and 7 walk through the diagnostic workup and the main treatment paths. Chapters 8 and 9 deal with the practical, daily-life side: eating, energy, sleep, mood. Chapter 10 is written for the people supporting you. And Chapter 11 closes on where research is heading and how to find trials and advocacy groups if you want them.

Right now, the more useful next step is smaller than all of that. The next chapter takes you inside the organ itself, so that when your care team mentions "exocrine function" or points at a scan and traces where the tumor sits, you'll already know what job that tissue was doing before cancer showed up.

End of free sample. The full book picks up right where this leaves off.